肠易激综合征与骨质疏松症关联的系统综述与荟萃分析
该系统综述与荟萃分析检索MEDLINE、EMBASE和Google Scholar至2019年10月,纳入4项队列研究和1项横断面研究共526,633名参与者,发现肠易激综合征患者骨质疏松风险显著升高(合并RR 1.95,95%CI 1.04-3.64),但异质性极高;骨折风险升高未达统计学显著性。
要点
- 肠易激综合征患者骨质疏松风险显著高于无肠易激综合征者,合并RR为1.95。
- 仅纳入队列研究的敏感性分析显示骨质疏松风险仍升高,合并RR为1.55。
- 骨折风险合并RR为1.58但未达统计学显著性,仅队列研究敏感性分析RR为1.27。
核心结论
- 肠易激综合征患者骨质疏松风险显著增加,早期预防干预如负重运动、补充维生素D和钙及早期筛查可能有益。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE和Google Scholar至2019年10月,纳入4项队列研究和1项横断面研究共526,633名参与者。
主要发现
- 5项研究均调查肠易激综合征患者骨质疏松风险,合并分析显示风险显著升高,合并RR为1.95(95%CI 1.04-3.64;I2 100%)。
- 仅纳入队列研究的敏感性分析显示骨质疏松合并RR为1.55(95%CI 1.39-1.72;I2 59%)。
- 3项研究调查骨质疏松性骨折风险,合并RR为1.58(95%CI 0.95-2.62;I2 99%),未达统计学显著性。
- 仅纳入队列研究的骨折敏感性分析显示合并RR为1.27(95%CI 1.20-1.39;I2 0%)。
临床怎么用
- 对肠易激综合征患者可考虑早期筛查骨质疏松并建议负重运动、补充维生素D和钙以预防骨质疏松发生。
局限性
- 异质性高且依赖诊断编码。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent studies have suggested that irritable bowel syndrome (IBS) could be a risk factor for osteoporosis although the evidence is still limited. The current study aimed to comprehensively examine the risk of osteoporosis among patients with IBS using systematic review and meta-analysis technique. METHODOLOGY: Literature search was independently conducted by two investigators using MEDLINE, EMBASE, and Google Scholar database up to October 2019. Eligible study must evaluate whether patients with IBS have a higher risk of osteoporosis and/or osteoporotic fracture. It could be either cross-sectional study, case-control study, or cohort study. Point estimates and standard errors from each eligible study were combined together using the generic inverse variance method of DerSimonian and Laird. RESULTS: Of the 320 articles identified from the three databases, four cohort and one cross-sectional study with 526,633 participants met the eligibility criteria and were included into the meta-analysis. All five studies investigated the risk of osteoporosis among patients with IBS, and the pooled analysis found that patients with IBS had a significantly higher risk of osteoporosis than individuals without IBS with the pooled risk ratio of 1.95 (95% CI, 1.04-3.64; I2 100%). Sensitivity analysis including only cohort studies found a lower RR (pooled RR 1.55; 95% CI, 1.39-1.72) with a lower I2 (59%). Three studies investigated the risk of osteoporotic fracture, and the pooled analysis found that patients with IBS also had a higher risk of osteoporotic fracture than individuals without IBS with the pooled risk ratio of 1.58 although statistical significance was not reached (95% CI, 0.95-2.62; I2 99%). Sensitivity analysis including only cohort studies found a lower RR (pooled RR 1.27; 95% CI, 1.20-1.39) with a dramatically lower I2 (0%). Limitations included high heterogeneity and reliance on diagnostic codes. CONCLUSION: A significantly increased risk of osteoporosis among IBS patients was observed in this study. Early intervention to prevent the development of osteoporosis, such as weight-bearing exercise, adequate intake of vitamin D and calcium, and early screening for osteoporosis, may be beneficial to these patients although further studies are still required to confirm the efficacy and cost-effectiveness of this approach.
引用
- Wongtrakul W, Charoenngam N, Ungprasert P, et al. The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis. Osteoporos Int. 2020. PMID: 32008157. doi:10.1007/s00198-020-05318-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。